TD Private Client Wealth’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$860 Buy
46
+8
+21% +$153 ﹤0.01% 1414
2025
Q4
$877 Sell
38
-23
-38% -$593 ﹤0.01% 1393
2025
Q3
$1.64K Buy
+61
New +$1.45K ﹤0.01% 1269
2024
Q1
Sell
-142
Closed -$4.43K 1266
2023
Q4
$4.43K Hold
142
﹤0.01% 1123
2023
Q3
$5.71K Sell
142
-3
-2% -$140 ﹤0.01% 1100
2023
Q2
$7.62K Hold
145
﹤0.01% 1087
2023
Q1
$9.27K Buy
145
+63
+77% +$4.11K ﹤0.01% 1045
2022
Q4
$3.98K Hold
82
﹤0.01% 1091
2022
Q3
$5.79K Buy
82
+3
+4% +$257 ﹤0.01% 1049
2022
Q2
$5.6K Buy
79
+18
+30% +$1.16K ﹤0.01% 1049
2022
Q1
$4.88K Buy
+61
New +$4.54K ﹤0.01% 1106

Other funds holding STAA

TD Private Client Wealth's STAA Position: Q1 2026 in Review

TD Private Client Wealth increased its STAAR Surgical (STAA) stake by 21% in Q1 2026, buying an estimated $153 and bringing the position to 46 shares worth $860. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

TD Private Client Wealth first reported a position in STAA in Q1 2022 and has held it in 11 quarters since. The position peaked at $9.27K in Q1 2023. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • TD Private Client Wealth held 46 shares of STAAR Surgical worth $860 as of Q1 2026.
  • TD Private Client Wealth bought 8 STAAR Surgical shares in Q1 2026, an estimated $153.
  • STAAR Surgical made up ﹤0.01% of TD Private Client Wealth's portfolio in Q1 2026, its #1414 holding.
  • TD Private Client Wealth first reported a position in STAAR Surgical in Q1 2022 and has held it in 11 quarters since.
  • TD Private Client Wealth's STAAR Surgical position peaked at $9.27K in Q1 2023.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.